FX006 40 mg

DRUG2 trials

Sponsors

Pacira Pharmaceuticals, Inc

Conditions

Osteoarthritis of the Knee

Phase 2

Pharmacokinetic and Pharmacodynamic Study of FX006 in Patients With Osteoarthritis of the Knee

CompletedNCT01487200

Pacira Pharmaceuticals, IncOsteoarthritis of the Knee

Start: 2012-07-31End: 2012-11-30Updated: 2024-01-24

Study to Characterize the Local Duration of Exposure From FX006 in Patients With Osteoarthritis of the Knee

CompletedNCT02003365

Pacira Pharmaceuticals, IncOsteoarthritis of the Knee

Start: 2013-11-30End: 2014-04-30Updated: 2024-01-24